MARINUS JACOBUS VERWIJS,RADHIKA KARKARE,MICHAEL DOUGLAS MOORE
申请号：
PT13792149
公开号：
PT2914248T
申请日:
2013.11.01
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
Pharmaceutical compositions comprising 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (Compound 1) in Form I and a solid dispersion comprising substantially amorphous N-(5-hydroxy-2,4-ditert-butyl-phenyl)-4-oxo-1H-quinoline-3-carboxamide (Compound 2), methods of treating, lessening the severity of, or symptomatically treating CFTR mediated diseases, such as cystic fibrosis, methods of manufacturing, methods of administering, and kits thereof are disclosed.
